Search Results 21-30 of 16461 for Strontium-89
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
... SR, Patel SH, Vora SA, Shen J, Liu W. Robust ... SR, Schild SE, Bues M, Li S, Liu T, Shen J, Wong ... 2000 Nov 1; 89(9):1946-52. View PubMed; Vora SA ...
89 · 90 · 91 · 92 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...
[MUSIC PLAYING]. Dan Childs, M.D., Oncologist: For a long time, we thought advanced prostate cancer was incurable. But now we see some men who have come in ...
Learn of Mayo Clinic's capabilities in nuclear medicine therapy, including PRRT with Lutathera, which doctors use to treat neuroendocrine tumors.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 in ...
Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.
Patients who have previously received denosumab; Patients who have previously received mithramycin, strontium-89, samarium-153 or rhenium; Patients receiving ...
... SR, Dingli D, Kumar S, Bergsagel L, Munoz JL ... 2015 Feb 1; 89(3):1945-6. View PubMed; Ayala ... 2014 Jul; 89 (7):926-33 Epub 2014 May 14. View PubMed ...
Learn how radiopharmaceuticals are used in nuclear medicine to diagnose conditions and treat diseases. Find out more about these targeted radioactive ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.